Fibroadenoma News and Research

RSS

A tumor in the breast represents the most common complaint for which women consult a physician, referring to their change as a mass or a thickening. Approximately 70% of all breast tumors are benign, while fibroadenomas are considered the second most common benign breast lesion with an incidence of 18-20% (following omnipresent fibrocystic changes in the breast).

Cryoablation preferred option for treatment of breast fibroadenoma

Sanarus Inc., a developer of minimally invasive diagnostic and treatment tools for breast disease, announced today that twelve-month follow-up data from a peer-reviewed, prospective multicenter study demonstrates that cryoablation is a preferred first-line treatment for breast fibroadenoma for women who do not want to undergo open surgery.

14 Sep 2004

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Fibroadenoma News and Research

Further Reading

Cryoablation preferred option for treatment of breast fibroadenoma

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News